Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 049558/0751 | |
| Pages: | 2 |
| | Recorded: | 06/21/2019 | | |
| Attorney Dkt #: | TECH:1179 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/08/2022
|
Application #:
|
16374026
|
Filing Dt:
|
04/03/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/03/2019
| | | | |
|
Title:
|
CRM1 INHIBITORS REDUCE PRIMARY AND ACQUIRED RESISTANCE OF EGFR INHIBITORS IN LUNG CANCER CELLS
|
|
|
Assignee
|
|
|
|
|
| OFFICE OF RESEARCH COMMERCIALIZATION |
| P.O. BOX 42007 |
| LUBBOCK, TEXAS 79409 |
|
|
Correspondence name and address
|
| |
LAURA DACONCEICAO
|
| |
CHALKER FLORES, LLP
|
| |
14951 NORTH DALLAS PARKWAY, SUITE 400
|
| |
DALLAS, TX 75254
|
Search Results as of:
09/25/2024 06:04 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
